Patent · US Active

1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazoles as 5-hydroxytryptamine-6 ligands

US8063053B2 · kind B2 · utility

1Cited by

12References

18Claims

0Family size

Assignee

Wyeth, LLC · US

Inventors

Simon Nicolas Haydar · South San Francisco, US
Patrick Michael Andrae · New Brunswick, US
Heedong Yun · Tenafly, US
Albert Jean Robichaud · Boston, US

Key dates

Filing date	Nov 11, 2009
Grant date	Nov 22, 2011
Priority date	—
Expiry date	Nov 11, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 1-(arylsulfonyl)-4-(piperazin-1-yl)-1H-benzimidazole compounds of the Formula I:or a tautomer, stereoisomer, or pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.